CCSI'capitalization as of 7/28/97 is as follows.7,417,987 common and 1,160,815 warrants,many of which have been excercised this week.So fully diluted,which it will be by date of expiration of the warrants 11/5/97 is 8.577mm shares.
As to size of market of bilirubin market,I stand corrected with a caveat.I spoke to a leading medical analyst in the street this am.#1 medical device for angioplasty $2.7billion #2 Pacemaker $2.5 billion #3 stent $1.0 billion.Now I put CCSI above stent,but below the others.However,the top 2 markets are served by more than 1 company,and CCSI's market is to be served strictly by CCSI.Therefore,I stick to my opinion that this is the largest device in history,but I will add,served by one firm
There still is a very large market in cosmetics,dental,industrial,consumer,which IMO will be as large as bilirubin,so I believe this is a two edged sword.
I will have phone number and time for conference call on 8/12,and will post it here,because to get back to all of you would not allow much time for sleep. |
